Logo

Caris

Caris Life Sciences, Fueled by New Funding, Plans to Expand Liquid Biopsy Testing
Premium

The company expects to launch testing for advanced cancer patients this year, with studies now running to expand to cancer screening and monitoring applications.

Caris Life Sciences Raises $830M to Support Precision Medicine Platform, Liquid Biopsy Development

The funds will help support Caris' ongoing commercial efforts in comprehensive cancer genomics as it makes new forays into liquid biopsy for multi-cancer early detection.

In Brief This Week: Bio-Techne, Dante Labs, Metagenomi, Applied DNA Sciences, Caris Life Sciences

News items for the week of April 5, 2021.

New Products Posted to GenomeWeb: Caris Life Sciences, Qlucore, Biocartis, More

Caris Shares Data for AI-Driven Tumor Origin Prediction, Hinting at Diagnostic, Patient Benefit
Premium

Investigators reported that the classifier could correctly predict cancer type with over 94 percent accuracy and highlighted impacts in a commercially tested cohort.

Dec 9, 2020

Caris Shares Full Chemo Personalization Assay Data for Colon Cancer; Plans for Other Tumor Types
Premium

Dec 9, 2020

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Dec 4, 2020

In Brief This Week: OmniSeq, Sema4, Yourgene, IDbyDNA, and More

Oct 27, 2020

Caris Life Sciences Raises $310M Through Equity, Debt Financing

Oct 16, 2020

New Products Posted to GenomeWeb: IDbyDNA/Illumina, Caris Life Sciences, Paragon Genomics, More

Oct 2, 2020

In Brief This Week: Illumina, BGI, Thermo Fisher, Genetron, Yourgene, Caris Life Sciences, More

Aug 11, 2020

Caris Life Sciences, Elevation Oncology Partner on Patient Enrollment for Tumor-Agnostic Drug Trial

Jul 14, 2020

Merus, Caris Life Sciences Partner to ID NRG1 Fusion-Positive Cancer Patients for Clinical Trial

May 7, 2020

Caris Life Sciences' MI FOLFOXai Predictor Brings Precision to Colorectal Cancer Chemo Decisions
Premium

Apr 28, 2020

Caris Life Sciences Seeks FDA Approval for Exome, Transcriptome CDx Assays

Apr 23, 2020

New Products Posted to GenomeWeb: Caris Life Sciences, Biocept, Sengenics, More

Apr 19, 2020

Despite FDA Guidance, CDx Providers Still Have Challenges in Seeking 'Therapeutic Group' Indication
Premium

Jan 15, 2020

JP Morgan Healthcare Day 2: 10x Genomics, GenapSys, Caris, Adaptive Bio, Danaher, Agilent, Luminex

Dec 13, 2019

New Products Posted to GenomeWeb: Horizon Discovery, Fluxion Biosciences, Caris Life Sciences, More

Dec 4, 2019

Ambry Genetics, Caris Life Sciences Partner on Cancer Genetic Testing

Oct 28, 2019

Genomic Test Makers Pilot New Approaches to Overcome Roadblocks in CUP Patient Treatment
Premium

Aug 26, 2019

Stakeholders Voice Concerns, Push Back on NCD for NGS Cancer Panels
Premium

Jun 20, 2019

With US Congress Considering Changes to Patent Laws, Dx Stakeholders Offer Differing Views
Premium

Jun 6, 2019

TAPUR Study Investigators Report First Positive Findings, Pursuing Tissue-Agnostic Cohorts
Premium

May 30, 2019

Caris Life Sciences Plans Integrated Molecular Testing, Trial Matching Service With New Acquisition
Premium

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.